ASTH
Astrana Health, Inc.
Key Financials
Gross Profit
$1.4M
↓ 3.6%
Operating Income
$78.5M
↓ 12.1%
Revenue
$3.2B
↑ 56.4%
Net Income
$22.5M
↓ 47.9%
EPS (Diluted)
$0.46
↓ 48.9%
Total Assets
$2.2B
↑ 63.8%
Total Liabilities
$1.7B
↑ 97.5%
Shareholders' Equity
$779.3M
↑ 9.3%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 6/12/2026 | View on SEC |
| 4 | 6/12/2026 | View on SEC |
| 4 | 6/12/2026 | View on SEC |
| 4 | 6/12/2026 | View on SEC |
| 4 | 6/12/2026 | View on SEC |
| 4 | 6/12/2026 | View on SEC |
| S-8 | 6/11/2026 | View on SEC |
| 8-K | 6/10/2026 | View on SEC |
| 4 | 5/18/2026 | View on SEC |
| 8-K | 5/12/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ASTH |
| Company Name | Astrana Health, Inc. |
| CIK | 1083446 |
| Sector | Services-Management Consulting Services |
| Industry | Large accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 8742 |
| SIC Description | Services-Management Consulting Services |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (626) 282-0288 |